Ram Mandalam is a visionary with a passion for developing innovative regenerative medicine therapies to treat serious conditions. Strategic and results-oriented biotechnology CEO with proven track record of leadership and execution. Over 25 years of executive and scientific experience, raising capital, and advancing programs from research through product development towards commercialization spanning public and private companies. He is the CEO and co-founder of Cellino, a startup that combines AI and regenerative medicine to create personalized therapies for heart disease using induced pluripotent stem cells.